Stock Events

Stock Events

Neogenomics 

$17.35
77
-$0.11-0.63% 19:39 Today

Statistics

Day High
17.44
Day Low
16.95
52W High
19.76
52W Low
7.07
Volume
11,120
Avg. Volume
-
Mkt Cap
2.23B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.01
0.01
0.03
0.05
Expected EPS
0.053636
Actual EPS
N/A

Financials

-14.85%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
727.33MRevenue
-108.03MNet Income

Analyst Ratings

18.50Average Price Target
The highest estimate is 25.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NEO. It's not an investment recommendation.
Apple
18
AAPL
Microsoft
18
MSFT
Amazon
18
AMZN
Tesla
17
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health offers liquid biopsy tests that compete with Neogenomics' molecular diagnostic solutions for cancer.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides genomic sequencing solutions and services, competing in the broader genomics and cancer diagnostics market alongside Neogenomics.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the genetic testing space with Neogenomics.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen offers sample to insight solutions including cancer diagnostics, competing in the molecular diagnostics market.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories offers products and services in the field of clinical diagnostics and life science research, competing with Neogenomics in diagnostics and genomic testing.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics provides diagnostic testing services, including for cancer, competing with Neogenomics in the diagnostics market.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America offers a range of healthcare diagnostics, including cancer diagnostics, competing directly with Neogenomics.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers products and services for the diagnostics and research markets, including cancer genomics, competing with Neogenomics in providing comprehensive solutions for genomic analysis.

About

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Show more...
CEO
Anthony Zook
Employees
2500
Country
United States
ISIN
US64049M2098
WKN
000120159

Listings

STU
DE
NG9.STU
MU
DE
NG9.MU
MX
MX
NEO.MX
XNAS
US
NEO

0 Comments

Share your thoughts

FAQ

What is Neogenomics stock price today?▼
The current price of NEO is $17.35 USD — it has decreased by -0.63% in the past 24 hours. Watch Neogenomics stock price performance more closely on the chart.
What is Neogenomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Neogenomics stocks are traded under the ticker NEO.
Is Neogenomics stock price growing?▼
NEO stock has fallen by -3.96% compared to the previous week, the month change is a +6.41% rise, over the last year Neogenomics has showed a +115.07% increase.
What is Neogenomics market cap?▼
Today Neogenomics has the market capitalization of 2.23B
When is the next Neogenomics earnings date?▼
Neogenomics is going to release the next earnings report on November 10, 2026.
What were Neogenomics earnings last quarter?▼
NEO earnings for the last quarter are 0.05 USD per share, whereas the estimation was 0.03 USD resulting in a +49.05% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Neogenomics revenue for the last year?▼
Neogenomics revenue for the last year amounts to 727.33M USD.
What is Neogenomics net income for the last year?▼
NEO net income for the last year is -108.03M USD.
How many employees does Neogenomics have?▼
As of September 04, 2026, the company has 2,500 employees.
In which sector is Neogenomics located?▼
Neogenomics operates in the Health & Wellness sector.
When did Neogenomics complete a stock split?▼
Neogenomics has not had any recent stock splits.
Where is Neogenomics headquartered?▼
Neogenomics is headquartered in FORT MYERS, United States.